These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
401 related items for PubMed ID: 12237925
1. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program. Geller AC, Sober AJ, Zhang Z, Brooks DR, Miller DR, Halpern A, Gilchrest BA. Cancer; 2002 Oct 01; 95(7):1554-61. PubMed ID: 12237925 [Abstract] [Full Text] [Related]
2. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. J Am Acad Dermatol; 2007 Jul 01; 57(1):60-6. PubMed ID: 17490783 [Abstract] [Full Text] [Related]
8. Who attends skin cancer clinics within a randomized melanoma screening program? Youl PH, Janda M, Elwood M, Lowe JB, Ring IT, Aitken JF. Cancer Detect Prev; 2006 Jul 01; 30(1):44-51. PubMed ID: 16457967 [Abstract] [Full Text] [Related]
9. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Swetter SM, Johnson TM, Miller DR, Layton CJ, Brooks KR, Geller AC. Arch Dermatol; 2009 Apr 01; 145(4):397-404. PubMed ID: 19380661 [Abstract] [Full Text] [Related]
10. Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia). Aitken JF, Janda M, Lowe JB, Elwood M, Ring IT, Youl PH, Firman DW. Cancer Causes Control; 2004 Jun 01; 15(5):453-63. PubMed ID: 15286465 [Abstract] [Full Text] [Related]
11. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece. Stratigos A, Nikolaou V, Kedicoglou S, Antoniou C, Stefanaki I, Haidemenos G, Katsambas AD. J Eur Acad Dermatol Venereol; 2007 Jan 01; 21(1):56-62. PubMed ID: 17207168 [Abstract] [Full Text] [Related]
12. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Bertoni JM, Arlette JP, Fernandez HH, Fitzer-Attas C, Frei K, Hassan MN, Isaacson SH, Lew MF, Molho E, Ondo WG, Phillips TJ, Singer C, Sutton JP, Wolf JE, North American Parkinson's and Melanoma Survey Investigators. Arch Neurol; 2010 Mar 01; 67(3):347-52. PubMed ID: 20212233 [Abstract] [Full Text] [Related]
13. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. Schneider JS, Moore DH, Mendelsohn ML. J Am Acad Dermatol; 2008 May 01; 58(5):741-9. PubMed ID: 18068264 [Abstract] [Full Text] [Related]
14. Evaluating the usefulness of self-reported risk factors in a skin cancer screening program. Williams HA, Fritschi L, Beauchamp C, Katris P. Melanoma Res; 2006 Aug 01; 16(4):341-5. PubMed ID: 16845330 [Abstract] [Full Text] [Related]
18. Validity of melanoma diagnosis in a community-based screening program. Fritschi L, Dye SA, Katris P. Am J Epidemiol; 2006 Aug 15; 164(4):385-90. PubMed ID: 16760225 [Abstract] [Full Text] [Related]